Hirsutism Due to Bilateral Leydig Cell Tumors

    Mohamed K M Shakir, Rinsha P V Sherin, Travis D. Weaver, David LaChance, Thanh D. Hoang
    Image of study
    TLDR A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.
    In 2020, a case was reported of a 61-year-old post-menopausal woman who presented with severe hirsutism and other signs of virilization, including increased facial hair growth, deepening of voice, clitoromegaly, alopecia, and acne. Her lab results showed significantly elevated levels of total and free testosterone, among other hormonal imbalances. Imaging with a transvaginal ultrasound did not reveal any ovarian pathology, but an MRI indicated bilateral ovarian enhancement. She underwent a laparoscopic bilateral oophorectomy, and pathology confirmed Leydig cell tumors (LCT) in both ovaries. Three months post-surgery, her hormonal levels normalized, and after six months, her symptoms of hirsutism and virilization significantly improved. This case underscores the importance of considering androgen-secreting tumors in post-menopausal women with hyperandrogenism and hirsutism, as imaging may not always detect such tumors and sometimes only pathology can confirm the diagnosis.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 3 weeks ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  12 upvotes 10 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    1 / 1 results